AAOS Now / Issue
The American Academy of Orthopaedic Surgeons announced a strategic investment in the field of biologics. Over the next five years, the AAOS will prioritize research and development for a biologics-focused competency within the Academy’s existing business.
Some AAOS Now articles are available only to AAOS members. Please log in to access this article.
Not a member? Become a member.
